These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 9119287)

  • 1. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The APTT response of pregnant plasma to unfractionated heparin.
    Chunilal SD; Young E; Johnston MA; Robertson C; Naguit I; Stevens P; Galashan D; Oskamp ML; Brennan B; Ginsberg JS
    Thromb Haemost; 2002 Jan; 87(1):92-7. PubMed ID: 11848463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasma.
    Koestenberger M; Gallistl S; Muntean W; Leschnik B; Fritsch P; Cvirn G
    Thromb Haemost; 2005 Jul; 94(1):69-74. PubMed ID: 16113786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant properties of a sulfated galactan preparation from a marine green alga, Codium cylindricum.
    Matsubara K; Matsuura Y; Bacic A; Liao M; Hori K; Miyazawa K
    Int J Biol Macromol; 2001 Jun; 28(5):395-9. PubMed ID: 11325427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
    Dempfle CE; Eichner J; Suvajac N; Ahmad-Nejad P; Neumaier M; Borggrefe M
    Anesth Analg; 2009 Sep; 109(3):712-6. PubMed ID: 19690236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intersubject variability in the anticoagulant response to heparin in vitro.
    Bjornsson TD; Wolfram KM
    Eur J Clin Pharmacol; 1982; 21(6):491-7. PubMed ID: 6176454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.
    Despotis GJ; Hogue CW; Santoro SA; Joist JH; Barnes PW; Lappas DG
    Crit Care Med; 1995 Oct; 23(10):1674-9. PubMed ID: 7587232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of low molecular weight heparin effect on the relation between anticoagulant activity and antithrombin III affinity.
    Hamano S; Nishiyama M; Kikuchi S; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
    Thromb Res; 1992 May; 66(4):299-307. PubMed ID: 1329257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
    Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
    Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition of unfractionated heparin and idraparinux on activated partial thromboplastin time and effect of exogenous antithrombin.
    Gouin-Thibault I; Samama MM
    Thromb Haemost; 2009 May; 101(5):986-7. PubMed ID: 19404557
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin.
    Lehman CM; Rettmann JA; Wilson LW; Markewitz BA
    Am J Clin Pathol; 2006 Sep; 126(3):416-21. PubMed ID: 16880140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin concentrate in pediatric patients requiring unfractionated heparin anticoagulation: a retrospective cohort study.
    Ryerson LM; Bauman ME; Kuhle S; Bruce AA; Massicotte MP
    Pediatr Crit Care Med; 2014 Oct; 15(8):e340-6. PubMed ID: 24901804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ; Slappendel RJ; van den Brom WE
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase.
    Anderson JA; Fredenburgh JC; Stafford AR; Guo YS; Hirsh J; Ghazarossian V; Weitz JI
    J Biol Chem; 2001 Mar; 276(13):9755-61. PubMed ID: 11134031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of in vitro interaction between heparin and nitroglycerin.
    Barnes AD; Horn JR; Wittkowsky AK
    Am J Clin Pathol; 1996 Mar; 105(3):298-300. PubMed ID: 8602610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo age dependency of unfractionated heparin in infants and children.
    Newall F; Ignjatovic V; Summerhayes R; Gan A; Butt W; Johnston L; Monagle P
    Thromb Res; 2009 Mar; 123(5):710-4. PubMed ID: 18829072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.